238 related articles for article (PubMed ID: 28440111)
1. Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
Adam S; Afifi H; Thomas M; Magdy P; El-Kamah G
Hemoglobin; 2017 Jan; 41(1):16-20. PubMed ID: 28440111
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ß-thalassemia in upper Egypt (single center study).
Hakeem GLA; Mousa SO; Moustafa AN; Mahgoob MH; Hassan EE
Health Qual Life Outcomes; 2018 Apr; 16(1):59. PubMed ID: 29631616
[TBL] [Abstract][Full Text] [Related]
3. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
Haghpanah S; Vahdati S; Karimi M
Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
[TBL] [Abstract][Full Text] [Related]
5. Impact of Burden of Thalassemia Major on Health-related Quality of Life in Omani Children.
Mevada ST; Al Saadoon M; Zachariah M; Al Rawas AH; Wali Y
J Pediatr Hematol Oncol; 2016 Jul; 38(5):384-8. PubMed ID: 27164523
[TBL] [Abstract][Full Text] [Related]
6. Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore.
Lam JCM; Lee SY; Koh PL; Fong SZ; Abdul-Kadir NI; Lim CY; Zhang X; Bhattacharyya R; Soh SY; Chan MY; Tan AM; Kuperan P; Ang AL
Blood Cells Mol Dis; 2021 May; 88():102547. PubMed ID: 33607590
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.
Piga A; Longo F; Gamberini MR; Voskaridou E; Ricchi P; Caruso V; Pietrangelo A; Zhang X; Shetty JK; Attie KM; Tartaglione I
Ther Adv Hematol; 2022; 13():20406207221134404. PubMed ID: 36505885
[TBL] [Abstract][Full Text] [Related]
8. Health-related Quality of Life and its Predictors Among Transfusion-dependent Thalassemia Patients.
Tuysuz G; Tayfun F
J Pediatr Hematol Oncol; 2017 Jul; 39(5):332-336. PubMed ID: 28221267
[TBL] [Abstract][Full Text] [Related]
9. Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.
Abu Samra O; Auda W; Kamhawy H; Al-Tonbary Y
Hematology; 2015 Jun; 20(5):297-303. PubMed ID: 25181014
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting quality of life in children and adolescents with thalassemia in Iraqi Kurdistan.
Mikael NA; Al-Allawi NA
Saudi Med J; 2018 Aug; 39(8):799-807. PubMed ID: 30106418
[TBL] [Abstract][Full Text] [Related]
11. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
[TBL] [Abstract][Full Text] [Related]
12. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
13. Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt.
Adly AA; Ebeid FS
J Pediatr Hematol Oncol; 2015 May; 37(4):281-4. PubMed ID: 25811748
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life of Pakistani Children with β-Thalassemia Major.
Yasmeen H; Hasnain S
Hemoglobin; 2018; 42(5-6):320-325. PubMed ID: 30700180
[TBL] [Abstract][Full Text] [Related]
15. Health-related Quality of Life in Children and Adolescents With β-Thalassemia Major on Different Iron Chelators in Basra, Iraq.
Abdul-Zahra HA; Hassan MK; Ahmed BA
J Pediatr Hematol Oncol; 2016 Oct; 38(7):503-11. PubMed ID: 27606437
[TBL] [Abstract][Full Text] [Related]
16. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
17. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life and Depression in Turkish Patients with β-Thalassemia Major: A Cross-Sectional Study.
Töret E; Karadaş NÖ; Gökçe NÖ; Kaygusuz A; Karapınar TH; Oymak Y; Gözmen S
Hemoglobin; 2018; 42(5-6):326-329. PubMed ID: 30672351
[TBL] [Abstract][Full Text] [Related]
19. Health-Related Quality of Life in Adolescents with Thalassemia.
Boonchooduang N; Louthrenoo O; Choeyprasert W; Charoenkwan P
Pediatr Hematol Oncol; 2015; 32(5):341-8. PubMed ID: 26086564
[TBL] [Abstract][Full Text] [Related]
20. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study.
Scalone L; Mantovani LG; Krol M; Rofail D; Ravera S; Bisconte MG; Borgna-Pignatti C; Borsellino Z; Cianciulli P; Gallisai D; Prossomariti L; Stefàno I; Cappellini MD
Curr Med Res Opin; 2008 Jul; 24(7):1905-17. PubMed ID: 18507891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
